Gastroenterology
Volume 119, Issue 6 , Pages 1631-1636, December 2000

Epidemiology and natural history of primary biliary cirrhosis in a U.S. community☆☆

*Division of Gastroenterology and Hepatology, Department of Health Sciences Research, and §Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, and Department of Research, Olmsted Medical Center, Rochester, Minnesota

Received 8 November 1999; accepted 12 July 2000.

Abstract 

Background & Aims: The epidemiology of primary biliary cirrhosis (PBC) has not been studied systematically in the United States. We report the incidence and prevalence of this condition in the general population. We also examined the validity of the Mayo natural history model for PBC among these unselected patients from the community. Methods: The Rochester Epidemiology Project entails a computerized index of diagnoses from the health care encounters of residents of Olmsted County, Minnesota. For potential cases identified using this database, the complete (inpatient and outpatient) medical records were reviewed to verify the diagnosis and extract information necessary for the application of the Mayo model. We estimated the incidence and prevalence of PBC in this population and compared the actual survival of patients with PBC in the community with the survival predicted for PBC patients by the Mayo natural history model. Results: The age-adjusted (to 1990 U.S. whites) incidence of PBC per 100,000 person-years for years 1975–1995 was 4.5 (95% confidence interval [CI], 3.1–5.9) for women, 0.7 (95% CI, 0.1–1.3) for men, and 2.7 (95% CI, 1.9–3.5) overall. The age- and sex-adjusted prevalence per 100,000 persons as of 1995 was 65.4 (95% CI, 43.0–87.9) for women, 12.1 (95% CI, 1.1–23.1) for men, and 40.2 (95% CI, 27.2–53.1) overall. The Mayo natural history model accurately predicted the actual survival of these patients. Conclusions: This first description of the epidemiology of PBC in the United States indicates that its incidence and prevalence in this country are among the highest reported. Outcomes among these unselected patients from a community population further validated the Mayo natural history model of PBC.

GASTROENTEROLOGY 2000;119:1631-1636

Abbreviations:  AMA , antimitochondrial antibody, 95% CI , 95% confidence interval, PBC , primary biliary cirrhosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address requests for reprints to: W. Ray Kim, M.D., Division of Gastroenterology and Hepatology (Ch10), Mayo Clinic and Foundation, 200 First Street S.W., Rochester, Minnesota 55905. e-mail: kim.woong@mayo.edu; fax: (507) 266-2810.

☆☆ Supported by grants DK34238 and AR30582 from the National Institutes of Health and the Mayo Foundation for Medical Research and Education.

PII: S0016-5085(00)10403-2

Gastroenterology
Volume 119, Issue 6 , Pages 1631-1636, December 2000